Lotfi, M., & Rezaei, N. (2020). CRISPR/Cas13: A potential therapeutic option of COVID-19. Elsevier.
Chicago Style (17th ed.) CitationLotfi, Melika, and Nima Rezaei. CRISPR/Cas13: A Potential Therapeutic Option of COVID-19. Elsevier, 2020.
MLA (8th ed.) CitationLotfi, Melika, and Nima Rezaei. CRISPR/Cas13: A Potential Therapeutic Option of COVID-19. Elsevier, 2020.
Warning: These citations may not always be 100% accurate.